Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2-59 months in Mongolia: an active pneumonia surveillance programme.

Autor: von Mollendorf C; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. Electronic address: claire.vonmollendorf@mcri.edu.au., Mungun T; National Center for Communicable Diseases, Ulaanbaatar, Mongolia., Ulziibayar M; National Center for Communicable Diseases, Ulaanbaatar, Mongolia., Nguyen CD; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia., Batsaikhan P; National Center for Communicable Diseases, Ulaanbaatar, Mongolia., Suuri B; National Center for Communicable Diseases, Ulaanbaatar, Mongolia., Luvsantseren D; National Center for Communicable Diseases, Ulaanbaatar, Mongolia., Narangerel D; Ministry of Health, Ulaanbaatar, Mongolia., Tsolmon B; National Center for Communicable Diseases, Ulaanbaatar, Mongolia; Institute of Biomedical Sciences, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Demberelsuren S; Expanded Programme on Immunization, WHO, Ulaanbaatar, Mongolia., Ortika BD; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Pell CL; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Wee-Hee A; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Nation ML; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Hinds J; Institute for Infection and Immunity, St George's, University of London, London, UK; BUGS Bioscience, London Bioscience Innovation Centre, London, UK., Dunne EM; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia., Mulholland EK; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia; Department of Infectious Disease Epidemiology and International Health, London School of Hygiene & Tropical Medicine, London, UK., Satzke C; Infection, Immunity and Global Health, Murdoch Children's Research Institute, Melbourne, VIC, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia; Department of Microbiology and Immunology, University of Melbourne-Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Dec; Vol. 5 (12), pp. 100929. Date of Electronic Publication: 2024 Oct 30.

Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study.

Autor: von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: annev@nicd.ac.za., Kleynhans J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., de Gouveia L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Tempia S; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Global Influenza Program, World Health Organization, Geneva, Switzerland., Meiring S; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Quan V; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., du Plessis M; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Paediatrics, Kalafong Provincial Tertiary Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., von Mollendorf C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Crowther-Gibson P; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Avenant T; Department of Paediatrics, Kalafong Provincial Tertiary Hospital, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., du Plessis N; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa., Kularatne R; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Rahima Moosa Mother and Child Hospital, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Chibabhai V; Charlotte Maxeke Johannesburg Academic Hospital, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Klugman KP; Pneumonia and Pandemic Prevention, Surveillance and Epidemic Control, Bill & Melinda Gates Foundation, Seattle, WA, USA., Whitney CG; Global Health Institute and Rollins School of Public Health, Emory University, Atlanta, GA, USA., Cohen C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: cherylc@nicd.ac.za.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Sep; Vol. 12 (9), pp. e1470-e1484.

Respiratory Syncytial Virus and Influenza Infections in Children in Ulaanbaatar, Mongolia, 2015-2021.

Autor: Do LAH; New Vaccines Group, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Tsedenbal N; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Khishigmunkh C; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Tserendulam B; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Altanbumba L; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Luvsantseren D; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Ulziibayar M; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Suuri B; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Narangerel D; National Center for Communicable Diseases, Ministry of Health, Ulaanbaatar, Mongolia., Tsolmon B; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia.; Medical Department, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Demberelsuren S; Expanded Program on Immunization, World Health Organization, Ulaanbaatar, Mongolia., Pell CL; Translational Microbiology Group, Murdoch Children's Research Institute, Melbourne, Australia., Manna S; Translational Microbiology Group, Murdoch Children's Research Institute, Melbourne, Australia., Satzke C; Department of Paediatrics, The University of Melbourne, Parkville, Australia.; Translational Microbiology Group, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia., Nguyen C; New Vaccines Group, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Mungun T; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., von Mollendorf C; New Vaccines Group, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Badarch D; Virology Department, National Center of Communicable Diseases, Ulaanbaatar, Mongolia., Mulholland K; New Vaccines Group, Murdoch Children's Research Institute, Melbourne, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia.; Infectious Disease Epidemiology & International Health, London School of Hygiene and Tropical Medicine, London, UK.

Publikováno v: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13303.

Measuring pneumococcal conjugate vaccine impact in a low-resource setting with minimal baseline data

Autor: von Mollendorf, C, Lim, R, Choummanivong, M, Sychareun, V, Vilivong, K, Lai, JYR, Chan, J, Dunne, EM, Phommachanh, S, Moore, K, Ortika, BD, Gray, A, Weaver, R, Mayxay, M, Phetsouvanh, R, Datta, SS, Fox, K, Newton, PN, Mulholland, EK, Nguyen, CD, Dance, DAB, Satzke, C, Xeuatvongsa, A, Russell, FM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::e6187202e5a97f262668289c3fe97837
https://doi.org/10.1093/ije/dyab168.687

Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.

Autor: von Mollendorf C, Ulziibayar M, Nguyen CD, Batsaikhan P, Suuri B, Luvsantseren D, Narangerel D, de Campo J, de Campo M, Tsolmon B, Demberelsuren S, Dunne EM, Satzke C, Mungun T, Mulholland EK

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2024 Mar; Vol. 30 (3), pp. 490-498.